My research focuses on inflammatory bowel disease specifically Crohn's disease and Ulcerative Colitis. My particular focuses include
1.) medical therapy of inflammatory bowel disease,
2.) safety of current medical therapy for IBD, and
3.) natural history of disease
Lichtenstein GR.: Inflammatory Bowel Disease Cecil’s Textbook of Medicine : 2015.
Scott F and Lichtenstein GR: The evaluation, diagnosis, and treatment of Inflammatory bowel diseases over the past 100 years: A brief review. Textbook on Endoscopy in IBD : 2015.
Buchner A and Lichtenstein GR.: The role of diet and nutrition in Inflammatory Bowel Disease Ulcerative Colitis. Medical therapy of Ulcerative Colitis (Textbook): : 2015.
Gary R Lichtenstein: Medical Therapy of Ulcerative colitis Textbook : 2015.
Mudireddy P, Blonski W, and Lichtenstein GR.: The History of Medical Therapy for Ulcerative Colitis Medical Therapy for Ulcerative Colitis. : 2015.
Mudireddy P, Blonski W, and Lichtenstein GR.: Contrast and Comparison of Mesalamine Derivatives for Treatment of Ulcerative Colitis Medical Therapy of ulcerative COlitis : 2015.
Rashid F and Lichtenstein GR.: Novel Biologic Therapies in Medical Therapy for Ulcerative Colitis. Medical Therapy of Ulcerative Colitis : 2015.
Bhotta G, Blonski W and Lichtenstein GR.: Cyclosporine A in Medical Therapy for Ulcerative Colitis. Medical Therapy of Ulcerative Colitis : 2015.
Tofani C, Valentin T, Tierney A, Lichtenstein GR.: IBD Is an Independent Risk Factor for Major Infectious Complications in Elderly Patients. Gastroenterology 146 (5 (1)): 2014.
Sandborn W, Scott DL, Randall CW, Gutierrez A, Schwartz DA, Ambarkhane S, Kayhan C, Pierre-Louis B, Kosutic G, Schreiber S, Lichtenstein GR: Long-Term Outcomes of Certolizumab Pegol for Crohn's Disease: 7 Year Results From the PRECiSE 3 Study. Gastroenterology. 146 (5): S-588-S-589,2014.
View all publications